Prediction of the Hepatic and Renal Clearance of Transporter Substrates in Rats Using in Vitro Uptake Experiments
暂无分享,去创建一个
Kazuya Maeda | Yuichi Sugiyama | Hiroyuki Kusuhara | K. Maeda | H. Kusuhara | Y. Sugiyama | S. Horita | Tomoko Watanabe | Tsunenori Kondo | Hideki Nakayama | Shigeru Horita | Tomoko Watanabe | T. Kondo | H. Nakayama
[1] A. Tsuji. Impact of transporter-mediated drug absorption, distribution, elimination and drug interactions in antimicrobial chemotherapy , 2006, Journal of infection and chemotherapy : official journal of the Japan Society of Chemotherapy.
[2] Jing-Tao Wu,et al. Strategy of utilizing in vitro and in vivo ADME tools for lead optimization and drug candidate selection. , 2005, Current topics in medicinal chemistry.
[3] K. Brouwer,et al. Impact of Basolateral Multidrug Resistance-Associated Protein (Mrp) 3 and Mrp4 on the Hepatobiliary Disposition of Fexofenadine in Perfused Mouse Livers , 2008, Drug Metabolism and Disposition.
[4] H. Kusuhara,et al. Functional involvement of rat organic anion transporter 3 (rOat3; Slc22a8) in the renal uptake of organic anions. , 2002, The Journal of pharmacology and experimental therapeutics.
[5] Yuichi Sugiyama,et al. Contribution of Organic Anion Transporters to the Renal Uptake of Anionic Compounds and Nucleoside Derivatives in Rat , 2003, Journal of Pharmacology and Experimental Therapeutics.
[6] M. Fromm,et al. Pharmacogenomics of human OATP transporters , 2006, Naunyn-Schmiedeberg's Archives of Pharmacology.
[7] Y. Sugiyama,et al. Temocaprilat, a novel angiotensin-converting enzyme inhibitor, is excreted in bile via an ATP-dependent active transporter (cMOAT) that is deficient in Eisai hyperbilirubinemic mutant rats (EHBR). , 1997, The Journal of pharmacology and experimental therapeutics.
[8] Y. Sugiyama,et al. Na(+)-independent multispecific anion transporter mediates active transport of pravastatin into rat liver. , 1993, The American journal of physiology.
[9] D. Putt,et al. Drug metabolism enzyme expression and activity in primary cultures of human proximal tubular cells. , 2008, Toxicology.
[10] M. Rowland,et al. Correlation between in‐vitro microsomal enzyme activity and whole organ hepatic elimination kinetics: analysis with a dispersion model , 1986, The Journal of pharmacy and pharmacology.
[11] D. Putt,et al. Membrane transport function in primary cultures of human proximal tubular cells. , 2006, Toxicology.
[12] Y. Sugiyama,et al. Transport of temocaprilat into rat hepatocytes: role of organic anion transporting polypeptide. , 1998, The Journal of pharmacology and experimental therapeutics.
[13] Y. Sugiyama,et al. Hepatobiliary transport governs overall elimination of peptidic endothelin antagonists in rats. , 1999, The Journal of pharmacology and experimental therapeutics.
[14] Roberts Sa,et al. High-throughput screening approaches for investigating drug metabolism and pharmacokinetics. , 2001 .
[15] K. Maeda,et al. Contribution of OATP2 (OATP1B1) and OATP8 (OATP1B3) to the Hepatic Uptake of Pitavastatin in Humans , 2004, Journal of Pharmacology and Experimental Therapeutics.
[16] S. Higuchi,et al. Genetic polymorphisms of drug transporters: pharmacokinetic and pharmacodynamic consequences in pharmacotherapy , 2006, Expert opinion on drug metabolism & toxicology.
[17] S. Roberts,et al. High-throughput screening approaches for investigating drug metabolism and pharmacokinetics , 2001, Xenobiotica; the fate of foreign compounds in biological systems.
[18] T. Lynch,et al. The effect of cytochrome P450 metabolism on drug response, interactions, and adverse effects. , 2007, American family physician.
[19] Y. Sugiyama,et al. Comparison of the Hepatic Uptake Clearances of Fifteen Drugs with a Wide Range of Membrane Permeabilities in Isolated Rat Hepatocytes and Perfused Rat Livers , 1993, Pharmaceutical Research.
[20] Diana Kazolias,et al. Use of Cryopreserved Human Hepatocytes in Sandwich Culture to Measure Hepatobiliary Transport , 2006, Drug Metabolism and Disposition.
[21] K. Maeda,et al. Recent progresses in the experimental methods and evaluation strategies of transporter functions for the prediction of the pharmacokinetics in humans , 2008, Naunyn-Schmiedeberg's Archives of Pharmacology.
[22] Yuichi Sugiyama,et al. Quantitative Evaluation of the Drug-Drug Interactions between Methotrexate and Nonsteroidal Anti-Inflammatory Drugs in the Renal Uptake Process Based on the Contribution of Organic Anion Transporters and Reduced Folate Carrier , 2004, Journal of Pharmacology and Experimental Therapeutics.
[23] Y. Sugiyama,et al. Gender difference in the Oatp1-mediated tubular reabsorption of estradiol 17beta-D-glucuronide in rats. , 2002, American journal of physiology. Endocrinology and metabolism.
[24] H. Kusuhara,et al. Gender Difference in the Urinary Excretion of Organic Anions in Rats , 2002, Journal of Pharmacology and Experimental Therapeutics.
[25] H. Takikawa,et al. Effects of colchicine and phenothiazine on biliary excretion of organic anions in rats , 1998, Journal of gastroenterology and hepatology.
[26] Tim Morris,et al. Physiological Parameters in Laboratory Animals and Humans , 1993, Pharmaceutical Research.
[27] K. Maeda,et al. Involvement of Multiple Efflux Transporters in Hepatic Disposition of Fexofenadine , 2008, Molecular Pharmacology.
[28] Yuichi Sugiyama,et al. Transporters as a determinant of drug clearance and tissue distribution. , 2006, European journal of pharmaceutical sciences : official journal of the European Federation for Pharmaceutical Sciences.
[29] T Iwatsubo,et al. PREDICTION OF IN VIVO DRUG DISPOSITION FROM IN VITRO DATA BASED ON PHYSIOLOGICAL PHARMACOKINETICS , 1996, Biopharmaceutics & drug disposition.
[30] Yuichi Sugiyama,et al. Evaluation of drug-drug interaction in the hepatobiliary and renal transport of drugs. , 2005, Annual review of pharmacology and toxicology.
[31] H. Kusuhara,et al. Increasing Systemic Exposure of Methotrexate by Active Efflux Mediated by Multidrug Resistance-Associated Protein 3 (Mrp3/Abcc3) , 2008, Journal of Pharmacology and Experimental Therapeutics.
[32] S. Furuta,et al. Pharmacokinetics of Temocapril and Enalapril in Patients with Various Degrees of Renal Insufficiency , 1993, Clinical pharmacokinetics.
[33] T Nakagawa,et al. A pharmacokinetic analysis program (multi) for microcomputer. , 1981, Journal of pharmacobio-dynamics.
[34] Y. Sugiyama,et al. Apical/Basolateral Surface Expression of Drug Transporters and its Role in Vectorial Drug Transport , 2005, Pharmaceutical Research.